193 related articles for article (PubMed ID: 37056926)
1. M6A-modified circRBM33 promotes prostate cancer progression via PDHA1-mediated mitochondrial respiration regulation and presents a potential target for ARSI therapy.
Zhong C; Long Z; Yang T; Wang S; Zhong W; Hu F; Teoh JY; Lu J; Mao X
Int J Biol Sci; 2023; 19(5):1543-1563. PubMed ID: 37056926
[TBL] [Abstract][Full Text] [Related]
2. Circular RNA RBM33 contributes to cervical cancer progression via modulation of the miR-758-3p/PUM2 axis.
Ding Y; Yuan X; Gu W
J Mol Histol; 2021 Apr; 52(2):173-185. PubMed ID: 33398465
[TBL] [Abstract][Full Text] [Related]
3. A prognostic signature consisting of N6-methyladenosine modified mRNAs demonstrates clinical potential in prediction of biochemical recurrence and guidance on precision therapy in prostate cancer.
Lu J; Chen J; Lin Z; Liu Q; Zhong C; Cai Z; Jia Z; Zhong W; Liang Y; Cai C
Transl Oncol; 2023 Jul; 33():101670. PubMed ID: 37060728
[TBL] [Abstract][Full Text] [Related]
4. CircRBM33 regulates IL-6 to promote gastric cancer progression through targeting miR-149.
Wang N; Lu K; Qu H; Wang H; Chen Y; Shan T; Ge X; Wei Y; Zhou P; Xia J
Biomed Pharmacother; 2020 May; 125():109876. PubMed ID: 32044717
[TBL] [Abstract][Full Text] [Related]
5. Activation of YAP1 by N6-Methyladenosine-Modified circCPSF6 Drives Malignancy in Hepatocellular Carcinoma.
Chen Y; Ling Z; Cai X; Xu Y; Lv Z; Man D; Ge J; Yu C; Zhang D; Zhang Y; Xie H; Zhou L; Wu J; Zheng S
Cancer Res; 2022 Feb; 82(4):599-614. PubMed ID: 34916222
[TBL] [Abstract][Full Text] [Related]
6. The METTL3 RNA Methyltransferase Regulates Transcriptional Networks in Prostate Cancer.
Haigh DB; Woodcock CL; Lothion-Roy J; Harris AE; Metzler VM; Persson JL; Robinson BD; Khani F; Alsaleem M; Ntekim A; Madhusudan S; Davis MB; Laursen KB; Gudas LJ; Rutland CS; Toss MS; Archer N; Bodi Z; Rakha EA; Fray RG; Jeyapalan JN; Mongan NP
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291932
[TBL] [Abstract][Full Text] [Related]
7. m6A-Mediated Biogenesis of circDDIT4 Inhibits Prostate Cancer Progression by Sequestrating ELAVL1/HuR.
Kong Z; Lu Y; Yang Y; Chang K; Lin Y; Huang Y; Wang C; Zhang L; Xu W; Zhao S; Li Y
Mol Cancer Res; 2023 Dec; 21(12):1342-1355. PubMed ID: 37647111
[TBL] [Abstract][Full Text] [Related]
8. Effect of circular RNAs and N6-methyladenosine (m6A) modification on cancer biology.
Zhang G; Hou J; Mei C; Wang X; Wang Y; Wang K
Biomed Pharmacother; 2023 Mar; 159():114260. PubMed ID: 36657303
[TBL] [Abstract][Full Text] [Related]
9. circRNA N6-methyladenosine methylation in preeclampsia and the potential role of N6-methyladenosine-modified circPAPPA2 in trophoblast invasion.
Zhang Y; Yang H; Long Y; Zhang Y; Chen R; Shi J; Chen J
Sci Rep; 2021 Dec; 11(1):24357. PubMed ID: 34934095
[TBL] [Abstract][Full Text] [Related]
10.
Pan J; Xing J; Yu H; Wang Z; Wang W; Pan Y
Ann Transl Med; 2023 Mar; 11(6):252. PubMed ID: 37082696
[TBL] [Abstract][Full Text] [Related]
11. ELK1-mediated YTHDF1 drives prostate cancer progression by facilitating the translation of Polo-like kinase 1 in an m6A dependent manner.
Li P; Shi Y; Gao D; Xu H; Zou Y; Wang Z; Li W
Int J Biol Sci; 2022; 18(16):6145-6162. PubMed ID: 36439881
[No Abstract] [Full Text] [Related]
12. Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signals.
Deng G; Wang R; Sun Y; Huang CP; Yeh S; You B; Feng C; Li G; Ma S; Chang C
Cell Death Differ; 2021 Jul; 28(7):2145-2159. PubMed ID: 34127806
[TBL] [Abstract][Full Text] [Related]
13. METTL3 promotes prostate cancer progression by regulating miR-182 maturation in m6A-dependent manner.
Wang D; Wang X; Huang B; Zhao Y; Tu W; Jin X; Shao Y; Zhu Y; Lu G
Andrologia; 2022 Aug; 54(7):1581-1591. PubMed ID: 35413135
[TBL] [Abstract][Full Text] [Related]
14. RNA N6-methyladenosine-modified-binding protein YTHDF1 promotes prostate cancer progression by regulating androgen function-related gene TRIM68.
Nie Q; Wu X; Huang Y; Guo T; Kuang J; Du C
Eur J Med Res; 2023 Dec; 28(1):552. PubMed ID: 38042806
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of m6A regulators prognostic value in prostate cancer.
Ji G; Huang C; He S; Gong Y; Song G; Li X; Zhou L
Aging (Albany NY); 2020 Jul; 12(14):14863-14884. PubMed ID: 32710725
[TBL] [Abstract][Full Text] [Related]
16. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
17. Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p.
Yu YZ; Lv DJ; Wang C; Song XL; Xie T; Wang T; Li ZM; Guo JD; Fu DJ; Li KJ; Wu DL; Chan FL; Feng NH; Chen ZS; Zhao SC
Mol Cancer; 2022 Jan; 21(1):12. PubMed ID: 34986849
[TBL] [Abstract][Full Text] [Related]
18. Co-transcriptional R-loops-mediated epigenetic regulation drives growth retardation and docetaxel chemosensitivity enhancement in advanced prostate cancer.
Ying Y; Wu Y; Zhang F; Tang Y; Yi J; Ma X; Li J; Chen D; Wang X; Liu X; Liu B; Luo J; Zheng X; Xie L
Mol Cancer; 2024 Apr; 23(1):79. PubMed ID: 38658974
[TBL] [Abstract][Full Text] [Related]
19. m6A-modified circABCC4 promotes stemness and metastasis of prostate cancer by recruiting IGF2BP2 to increase stability of CCAR1.
Huang C; Xu R; Zhu X; Jiang H
Cancer Gene Ther; 2023 Oct; 30(10):1426-1440. PubMed ID: 37563361
[TBL] [Abstract][Full Text] [Related]
20. n6-methyladenosine-modified circular RNA family with sequence similarity 126, member A affects cholesterol synthesis and malignant progression of prostate cancer cells by targeting microRNA-505-3p to mediate calnexin.
Luo L; Li P; Xie Q; Wu Y; Qin F; Liao D; Zeng K; Wang K
J Cancer; 2024; 15(4):966-980. PubMed ID: 38230215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
